Related Experiment Video
Updated: Jan 10, 2026

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
Published on: April 3, 2014
Synaptojanin-1 supports VPS35-dependent trafficking of dopamine D2 autoreceptors at presynaptic terminals
Pingyue Pan1, Nirmal Kumar1, Elnaz Khezerlou1
1Department of Neuroscience and Cell Biology, Rutgers University Robert Wood Johnson Medical School, 675 Hoes Lane West, Piscataway, NJ 08854, USA.
Abstract:
Synaptic dysfunction is a hallmark of early Parkinson's disease (PD), but molecular mechanisms underlying dopaminergic synaptic impairment and vulnerability remain poorly understood. Here, we identify a functional interaction between two PD genes, Synaptojanin1 and VPS35, in regulating endosomal sorting of the dopamine D2 short (D2S) autoreceptor, thereby modulating dopamine signaling. We show that Synaptojanin1 deficiency results in intracellular retention of the D2S, impaired gating of dopamine release and reduced behavioral responsiveness to a D2-like agonist. VPS35 is recruited to D2S-containing and Rab7a-positive endosomes in a Synj1-dependent manner, and VPS35 overexpression overcomes Synj1 deficiency-associated impairment in D2S surface delivery in axons. Moreover, Synj1 regulates VPS35 expression and localization in dopaminergic axons, indicating their broader roles in presynaptic cargo sorting. These findings reveal a novel cooperation between a synaptic vesicle endocytic regulator and a core component of the retromer complex, providing new mechanistic insights into presynaptic trafficking and its disruption in PD.
More Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Release or Uptake
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

